These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6518835)

  • 1. Penetration of parenterally administered rifampicin into bone tissue.
    Roth B
    Chemotherapy; 1984; 30(6):358-65. PubMed ID: 6518835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.
    Norden CW; Keleti E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):591-4. PubMed ID: 7396451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
    Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
    Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical use of Rifampicin in orthopedics and traumatology].
    Bianchi-Maiocchi A
    Minerva Med; 1969 Dec; 60(96):4853-6. PubMed ID: 4982678
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion.
    Houin G; Beucler A; Richelet S; Brioude R; Lafaix C; Tillement JP
    Ther Drug Monit; 1983; 5(1):67-72. PubMed ID: 6845401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on antibiotic therapy. 2) Rifampicin].
    Di Nola F
    Minerva Med; 1982 Feb; 73(7):357-62. PubMed ID: 7188493
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
    Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on rifampicin. I. Penetration into the bone in man after single dose of 750 mg.
    Vacek V; Hejzlar M; Pavlansky R
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):217-9. PubMed ID: 4917426
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
    Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
    Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
    Ziia AV; Sokolov GB; Firsov AA
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):223-7. PubMed ID: 3579252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin in the treatment of osteoarticular infections due to staphylococci.
    Cluzel RA; Lopitaux R; Sirot J; Rampon S
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():23-9. PubMed ID: 6469888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
    Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E
    Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone penetration of enoxacin in patients with and without osteomyelitis.
    Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
    Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study on intravenous rifampicin in man.
    Acocella G; Segre G; Conti R; Pagani V; Pallanza R; Perna G; Simone P
    Pharmacol Res Commun; 1984 Jul; 16(7):723-36. PubMed ID: 6473487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.